Sriker Nadipuram is a finance professional with a focus on the healthcare and biotechnology sectors. He currently serves as an Analyst specializing in Therapeutics at Casdin Capital.
His career history includes significant roles in equity research and analysis. Prior to his current position, Nadipuram was a Healthcare Analyst at Alliancebernstein and an Associate Director focusing on Pharma, Specialty US Pharma, and Biotech Equity Research at UBS.